Amira Haddad
Partner, London
Sectors
Health
Healthcare spends a remarkable share of its money on coordination: scheduling, approvals, recruitment, follow-up. We back companies that take that work off clinicians and give patients an answer sooner.
- companies
- 4
- active
- 2
- exits
- 2
- first investment
- 2017
What we look for
We prefer founders who have worked inside the system they are changing, and products that a hospital or clinic can adopt without rebuilding its workflow around them.
Care after discharge
Monitoring and diagnostics that move safely from the ward to the patient's home.
Clinical operations
Trial recruitment, prior authorisation and the administrative work that delays treatment.
Diagnostics at the edge
Lab-grade testing that happens closer to the patient and reports back faster.
Health companies
Open in the directoryWho to talk to
Ananya Rao
Associate, London
From the journal
Investor letters
Second-quarter letter, 2026
Our letter to the partners in our funds for the second quarter of 2026: two new Fund V investments, early results at Amperra and Kiln, and where Fund III stands after Ostra.
Grant Holloway and Sofia Ortega
Investor letters
Annual letter, 2025
Our annual letter to the partners in our funds: closing Fund V, the sale of Ostra, Tidewater's first year as a public company, and the first five Fund V investments.
Nadia Mensah and Theo Marchetti
News
Ostra joins Calder Health
Ostra, which helps hospitals find and enrol patients for clinical trials, has been acquired by Calder Health. A note on what the company built.
Amira Haddad